Long
SYN
SYNSynthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry
forbes.com/ - February 4 at 5:39 PM
Attention. important cash flow. we follow the news but from 0.88 to my aviso we are preparing to break the dollar and in the average two three months maximum to reach the spike a1.7 .... I am there and you?
If every idea of mine has led you to excellent results in terms of Gain, please acknowledge your support through a donation ... I WILL SEE AS A STIMULUS TO REWARD YOU OFTEN IN THIS 2021 ... Happy trading everyone and thanks for the support.
paypal.me/mauretto432
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.